Sitemap

  • Privacy Policy
  • Support our research
  • ARC Future Fellowships 2010–14
  • Epigenetic control of T cell development and function in infection
  • ARC Future Fellowships 2011–15
  • X Inactivation and Epigenetics
  • Scientists
  • Type 2 diabetes – new inflammation and cell death pathways
  • Targeting cell death pathways in parasites
  • Selective targeting of Bcl-2 proteins in cancer
  • The role and mechansim of apoptosis in haematopoiesis and cancer
  • Development of B cell memory and antibody responses to malaria
  • Investigating the CXCR3-directed coordination of viral responses
  • The role of SPSB1 in regulating the innate immune response
  • Delivery of RNAi therapeutics by the mammalian SID-1 orthologs
  • When splicing goes awry – a mechanism for cancer onset and progression?
  • Creating cancer models in zebrafish
  • Emerging roles for 'minor class' splicing in colorectal cancer - not so minor after all
  • Physiological regulators of ion channels
  • Drug discovery screening in zebrafish embryos
  • Red blood cell binding proteins of malaria parasites
  • Small molecule targeting of a ‘dead’ enzyme, MLKL
  • Investigating novel therapeutic modalities to treat chronic and overwhelming human infections
  • Biological sequence alignment
  • Innate immune regulation of metabolism and inflammatory bowel disease
  • Understanding how a ‘dead’ enzyme, MLKL, mediates cell death
  • Apoptosis regulation in angiogenic blood vessels
  • Bioinformatics methods for studying gene regulation in blood development
  • Hunting for mammalian cytosolic IAP regulators
  • Identification of new compounds and mechanisms for the treatment of leukaemia
  • How DNA methylation affects human autoimmune disease susceptibility
  • Molecular basis of the crosstalk between cell survival and cell death pathways
  • Tracking clonal diversity in breast cancer
  • Finding new targets for the treatment of leukaemia
  • The role of SIDT2 in tumour suppression
  • RNA exchange as a novel means of intercellular communication
  • Platelet function in cancer
  • Molecular regulation of antibody responses to different classes of pathogens
  • Development of malaria vaccines
  • Validation of novel markers for the detection of Plasmodium vivax gametocytes
  • Tumour suppressive mechanisms of CEBPA and PU.1 in acute myeloid leukaemia
  • Transcriptional and metabolomic profile of bacterial infections in diabetic hosts
  • Characterising the Bak apoptotic pore by mass spectrometry
  • Erythropoietic suppression in malaria
  • Design, synthesis and testing of novel bromodomain inhibitors
  • Testing a new theory of T cell regulation
  • Detection of alternative splicing from RNA-seq data
  • Leukaemia suppression by Pax5 and Ikaros
  • Investigating the formation and function of foetal platelets
  • Developing mass spectrometry tools for identifying novel cancer targets
  • Discovery of mutations in tumour genomes using reference genome-free methods
  • Blocking the mitochondrial pathway of cell death by sequestering the Bak protein
  • Gene expression signatures, pathway analysis and RNA-seq
  • The role of necroptosis and pyroptosis during infection
  • Understanding how BH3-only proteins initiate apoptosis
  • Role of the Hhex transcription factor in blood development and leukaemia
  • Post-translational modifications in apicomplexan parasites – new biology and therapeutic targets.
  • Role of cell death proteins in inflammatory disease
  • Regulating antiviral immunity
  • Natural killer cell development and homeostasis
  • The generation of pre-clinical models of squamous cell lung cancer
  • Understanding hematopoiesis at the single cell level
  • Identifying inhibitor of DNA binding protein partners in lymphocytes
  • The role of dysregulated RNA metabolism in myelodysplasia and leukaemia
  • Understanding the impact of cancer therapy on blood cell development
  • Synthesis and profiling of Selective TBK1 Inhibitors
  • Investigating the Bcl-2 family of apoptosis regulators in cells using novel imaging approaches
  • Population structure of Plasmodium vivax in the Solomon Islands
  • Genetic validation of Stat3 as a tractable pharmacological target in gastrointestinal cancer
  • Investigating the contribution of gp130 family cytokines in lung disease
  • Understanding the requirement for STAT3 activation during chronic inflammatory diseases and cancer
  • Targeting colorectal cancer with Jak tyrosine kinase inhibitors
  • Characterisation of potential new therapeutics for metastatic cancers
  • Characterising antibodies targeting the pro-apoptotic protein Bax
  • Defining the function of the interleukin-11 signalling complex
  • Metabolic regulation of lymphocyte differentiation and function during infection and immunity
  • Identification and functional characterisation of prognostic molecular markers in colorectal cancer
  • Characterisation of the role of a novel WNT/β-catenin pathway regulator in colorectal cancer
  • Virus one billion times
  • Inflammation and Type 2 Diabetes
  • Activation of invasion in Plasmodium and Toxoplasma parasites
  • Immune evasion strategies of malaria parasites
  • Structural characterisation of malaria parasite adhesins
  • How does the 'dead' enzyme MLKL induce cell death?
  • Emerging role of transmembrane pseudokinases in cancer
  • Sponsors

    Content on this page requires a newer version of Adobe Flash Player.

    Get Adobe Flash player

    Online donation form